Pharmacogenetics is capitalizing on the tools of the Human Genome Project to introduce the new genomic information into drug development. The applications vary from identifying individuals at risk for a disease, to developing gene signatures of drug efficacy and adverse effects. Pharmacogenetics is
โฆ LIBER โฆ
Proteomics: Applications and opportunities in preclinical drug development
โ Scribed by Sandra Steiner; Frank A. Witzmann
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 65 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Application of genetics and genomics in
โ
Mihael H. Polymeropoulos
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 54 KB
๐ 2 views
Principles of CNS Drug Development || Pr
โ
Kelly, John
๐
Article
๐
2010
๐
John Wiley & Sons, Ltd
โ 313 KB
๐ 1 views
Opportunities for Medication Development
โ
Richard B. Rothman; F. Ivy Carroll
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 51 KB
Principles of CNS Drug Development || CN
โ
Kelly, John
๐
Article
๐
2010
๐
John Wiley & Sons, Ltd
โ 356 KB
๐ 2 views
Emerging and recurrent issues in drug de
โ
Charles Anello
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 215 KB
๐ 1 views
This paper reviews several emerging and recurrent issues relating to the drug development process. These emerging issues include changes to the FDA regulatory environment, internationalization of drug development, advances in computer technology and visualization tools, and e!orts to incorporate met
Ethnobotany and its role in drug develop
โ
Michael Heinrich
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 108 KB
๐ 1 views